These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 19556497)
1. Medical innovation versus stem cell tourism. Lindvall O; Hyun I Science; 2009 Jun; 324(5935):1664-5. PubMed ID: 19556497 [TBL] [Abstract][Full Text] [Related]
2. Clinical trials in stem cell transplantation: guidelines for scientific and ethical review. Lo B; Kriegstein A; Grady D Clin Trials; 2008; 5(5):517-22. PubMed ID: 18827044 [TBL] [Abstract][Full Text] [Related]
3. Medical and surgical tourism: the new world of health care globalization and what it means for the practicing surgeon. Unti JA Bull Am Coll Surg; 2009 Apr; 94(4):18-25. PubMed ID: 19492750 [TBL] [Abstract][Full Text] [Related]
4. The Need for Beneficence and Prudence in Clinical Innovation with Autologous Stem Cells. Lipworth W; Stewart C; Kerridge I Perspect Biol Med; 2018; 61(1):90-105. PubMed ID: 29805150 [TBL] [Abstract][Full Text] [Related]
5. Medical tourism: the trend toward outsourcing medical procedures to foreign countries. York D J Contin Educ Health Prof; 2008; 28(2):99-102. PubMed ID: 18521877 [TBL] [Abstract][Full Text] [Related]
6. Mismanaging the gift of life: noncompliance in the context of adult stem cell transplantation. Bishop MM; Rodrigue JR; Wingard JR Bone Marrow Transplant; 2002 Jun; 29(11):875-80. PubMed ID: 12080350 [TBL] [Abstract][Full Text] [Related]
7. FDA regulation of stem cell-based products. Fink DW Science; 2009 Jun; 324(5935):1662-3. PubMed ID: 19556496 [TBL] [Abstract][Full Text] [Related]
8. Stem cell tourism and future stem cell tourists: policy and ethical implications. Einsiedel EF; Adamson H Dev World Bioeth; 2012 Apr; 12(1):35-44. PubMed ID: 22420450 [TBL] [Abstract][Full Text] [Related]
9. Texas signals support for unproven stem cell therapies. Servick K Science; 2017 Jun; 356(6344):1219. PubMed ID: 28642387 [No Abstract] [Full Text] [Related]
10. Stem cell therapies: on track but suffer setback. Gunzburg WH; Salmons B Curr Opin Mol Ther; 2009 Aug; 11(4):360-3. PubMed ID: 19649980 [No Abstract] [Full Text] [Related]
11. Concise Review: A Comprehensive Analysis of Reported Adverse Events in Patients Receiving Unproven Stem Cell-Based Interventions. Bauer G; Elsallab M; Abou-El-Enein M Stem Cells Transl Med; 2018 Sep; 7(9):676-685. PubMed ID: 30063299 [TBL] [Abstract][Full Text] [Related]
12. Allowing innovative stem cell-based therapies outside of clinical trials: ethical and policy challenges. Hyun I J Law Med Ethics; 2010; 38(2):277-85. PubMed ID: 20579251 [TBL] [Abstract][Full Text] [Related]
13. Cross-border issues in the development of medical tourism in Malaysia: legal challenges and opportunities. Nemie P; Kassim J J Law Med; 2009 Aug; 17(1):59-73. PubMed ID: 19771987 [TBL] [Abstract][Full Text] [Related]
14. Stem cell tourism--a challenge for trans-national governance. Shalev C Am J Bioeth; 2010 May; 10(5):40-2. PubMed ID: 20461648 [No Abstract] [Full Text] [Related]
15. Compassionate use in research. Miracle VA Dimens Crit Care Nurs; 2009; 28(2):85-8. PubMed ID: 19225323 [TBL] [Abstract][Full Text] [Related]
16. Unproven stem cell therapies: is it my right to try? Riva L; Campanozzi L; Vitali M; Ricci G; Tambone V Ann Ist Super Sanita; 2019; 55(2):179-185. PubMed ID: 31264641 [TBL] [Abstract][Full Text] [Related]